Advanced Search

 

Study ID Status Title Patient Level Data
204905 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SM Light Beige, in subjects with sensitive skin Under Normal Usage Conditions.
204906 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SM Medium Beige, in subjects with sensitive skin Under Normal Usage Conditions
204907 Withdrawn Skin Acceptability Assessment of the cosmetic product SM Translucent, in subjects with sensitive skin Under Normal Usage Conditions
204908 Not yet recruiting Skin Acceptability Assessment of the cosmetic product SM Peach Beige, in subjects with sensitive skin Under Normal Usage conditions
204917 Not yet recruiting Comedogenic and acnegenic potential evaluation with ophthalmologic evaluation of the cosmetic product SB Translucent - in-use study.
204918 Not yet recruiting Comedogenic and acnegenic potential evaluation with ophthalmologic evaluation of the cosmetic product SB Light Beige - in-use study.
204919 Not yet recruiting Comedogenic and acnegenic potential evaluation with ophthalmologic evaluation of the cosmetic product SB Peach Beige - in-use study.
204920 Not yet recruiting Comedogenic and acnegenic potential evaluation with ophthalmologic evaluation of the cosmetic product SB Medium Beige - in-use study.
204921 Not yet recruiting Comedogenic and acnegenic potential evaluation with ophthalmologic evaluation of the cosmetic product SM Light Beige - in-use study.
204922 Not yet recruiting Comedogenic and acnegenic potential evaluation with ophthalmologic evaluation of the cosmetic product SM Medium Beige - in-use study.
204923 Not yet recruiting Comedogenic and acnegenic potential evaluation with ophthalmologic evaluation of the cosmetic product SM Translucent - in-use study.
204924 Not yet recruiting Comedogenic and acnegenic potential evaluation with ophthalmologic evaluation of the cosmetic product SM Peach Beige - in-use study.
204926 Active not recruiting Long term immunogenicity and safety study of GSK Biologicals’ Herpes Zoster subunit (HZ/su) vaccine 1437173A and assessment of re-vaccination with 2 additional doses, in healthy subjects aged 60 years of age and older
204927 Completed PGx7643: Efficacy pharmacogenetic analysis of SLE patients treated with Benlysta in study BEL112341
204928 Recruiting Study to evaluate the impact of reactogenicity on Quality of Life (QoL), after administration of GSK Biologicals’ candidate Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A) in adults ≥ 50 years of age
204930 Completed Study to Investigate the Impact on Oral Health Related Quality of Life of Managing Dentine Hypersensitivity with a Daily Use Anti-Sensitivity Toothpaste
204943 Not yet recruiting PRJ2568: Comparing durability, treatment failure and emergence of resistance of integrase strand transfer inhibitor treatment regimens among treatment-naïve and treatment-experienced patients with HIV
204946 Completed A single center, two part, randomized, open label cross-over study to evaluate the effect of itraconazole and rifampicin on the pharmacokinetics of GSK525762 in healthy female subjects of non child bearing potential
204947 Recruiting A phase III study to evaluate the efficacy and safety of GSK1358820 (botulinum toxin type A) in patients with overactive bladder
204948 Recruiting A phase III study to evaluate the efficacy and safety of GSK1358820 (botulinum toxin type A) in patients with urinary incontinence due to neurogenic detrusor overactivity
204953 Completed A Double-Blind (Sponsor Unblinded), Randomized, Placebo-Controlled, Continuation Single and Repeated Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of GSK2838232 with Ritonavir, in Healthy Subjects
204957 Recruiting A randomised, multi-center, double blind (sponsor open), placebo-controlled study to assess the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of GSK3117391 in subjects with severe, active rheumatoid arthritis
204958 Recruiting An open label, randomised, three arm, single dose, multicentre, parallel group study in healthy subjects to compare the pharmacokinetics of subcutaneous mepolizumab when delivered as a liquid drug product in a safety syringe or an auto injector with a reconstituted lyophilised drug product from a vial
204959 Not yet recruiting An open-label, single arm, repeat dose, multi-centre study to evaluate the use of an autoinjector for the subcutaneous administration of mepolizumab in subjects with severe eosinophilic asthma (Study 204959)
204979 Completed A Single-Dose, Open-Label, Three-way Crossover Bioequivalence Study of Three, 2 mg Nicotine Chewing Gums (Two Tests and one Reference) in Chinese Male Healthy Adult Smokers

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.